On May 1, 2018, Sebela Pharmaceuticals completed the acquisition of Braintree Laboratories Inc., a privately held specialty pharmaceutical company based in Braintree, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology.
The WilmerHale deal team that counseled Braintree was led by Stuart Falber and included Keith Barnett, Steven Barrett, Robert Burke, Joseph Conahan, Julie Hogan Rodgers, Paul Jakubowski, Jeff Johnson, Rachael Kent, Amy Null, Justin Ochs, Hartmut Schneider, Laura Schneider, John Sigel, Kimberly Wethly, Brett Jackson, Michael Raine, Nicolette Anagnos and Ben Kelsey.